Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Finn

Showing results (201-210 of 235) with videos related to

Pageof 24
Sort By:
JAMA|November 2, 2021
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical TrialJulia A Bielicki, Wolfgang Stöhr, Sam Barratt, et al.
NPJ Vaccines|July 1, 2026
Safety and immunogenicity of concomitant quadrivalent meningococcus ACYW-TT and meningococcus group B vaccinesMonica A McArthur, Adam Finn, Lawrence Barnes, et al.
The Lancet. Infectious Diseases|January 12, 2015
Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trialMildred A Iro, Ameneh Khatami, Andrew S J Marshall, et al.
BJGP Open|September 9, 2024
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)Polly Duncan, Ruth Mears, Elizabeth Begier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyWoolf T Walker, Philip de Whalley, Nick Andrews, et al.
The Pediatric Infectious Disease Journal|December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trialMatthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
Elife|June 13, 2023
Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 monthsMarianna Santopaolo, Michaela Gregorova, Fergus Hamilton, et al.
Ejhaem|June 14, 2021
Blood group type A secretors are associated with a higher risk of COVID-19 cardiovascular disease complicationsTosti J Mankelow, Belinda K Singleton, Pedro L Moura, et al.
Vaccine|December 15, 2022
Prospective study of loss of health-related quality adjusted life years in children and their families due to uncomplicated and hospitalised varicellaFernanda Rodrigues, Robin Marlow, Catarina Gouveia, et al.
JAMA Network Open|October 12, 2021
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical TrialTimo Vesikari, Adam Finn, Pierre van Damme, et al.
Pageof 24

Showing results (201-210 of 235) with videos related to

Sort By:
Pageof 24
JAMA|November 2, 2021
Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical TrialJulia A Bielicki, Wolfgang Stöhr, Sam Barratt, et al.
NPJ Vaccines|July 1, 2026
Safety and immunogenicity of concomitant quadrivalent meningococcus ACYW-TT and meningococcus group B vaccinesMonica A McArthur, Adam Finn, Lawrence Barnes, et al.
The Lancet. Infectious Diseases|January 12, 2015
Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trialMildred A Iro, Ameneh Khatami, Andrew S J Marshall, et al.
BJGP Open|September 9, 2024
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)Polly Duncan, Ruth Mears, Elizabeth Begier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
H1N1 antibody persistence 1 year after immunization with an adjuvanted or whole-virion pandemic vaccine and immunogenicity and reactogenicity of subsequent seasonal influenza vaccine: a multicenter follow-on studyWoolf T Walker, Philip de Whalley, Nick Andrews, et al.
The Pediatric Infectious Disease Journal|December 15, 2010
Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trialMatthew D Snape, Chaam L Klinger, Elvis D Daniels, et al.
Elife|June 13, 2023
Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 monthsMarianna Santopaolo, Michaela Gregorova, Fergus Hamilton, et al.
Ejhaem|June 14, 2021
Blood group type A secretors are associated with a higher risk of COVID-19 cardiovascular disease complicationsTosti J Mankelow, Belinda K Singleton, Pedro L Moura, et al.
Vaccine|December 15, 2022
Prospective study of loss of health-related quality adjusted life years in children and their families due to uncomplicated and hospitalised varicellaFernanda Rodrigues, Robin Marlow, Catarina Gouveia, et al.
JAMA Network Open|October 12, 2021
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical TrialTimo Vesikari, Adam Finn, Pierre van Damme, et al.
Pageof 24